EUVIMEDEUVIMED entdecken
Crossref

ThyroSeq overview on indeterminate thyroid nodules: An institutional experience

Sam Sirotnikov, Christopher C Griffith, Daniel Lubin iD, Chao Zhang, Nabil F Saba, Dehong Li, Amanda Kornfield, Amy Chen, Qiuying Shi iD

Diagnostic Cytopathology · 2024

DOI: 10.1002/dc.25311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostic Cytopathology, 2024. Verfasst von Sam Sirotnikov und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Thyroid Nodule. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Molecular triage of indeterminate thyroid aspirates offers the opportunity to stratify the risk of malignancy (ROM) more accurately. Here we examine our experience with ThyroSeq v3 testing.

Methods

We analyzed 276 of 658 (42%) fine needle aspiration samples classified as indeterminate thyroid nodules using ThyroSeq v3 (Sept 2017–Dec 2019). The test provides a ROM and detects specific mutations. Surgical diagnoses were reviewed.

Results

Of 276 ThyroSeq‐tested cases, 42% ( n = 116) harbored genetic alterations, whereas 64% ( n = 74) had surgical follow‐up. Notably, 79% cases within intermediate to higher risk mutations were highly associated with surgical intervention, resulting in a 77.5% ROM when including both cancer and noninvasive follicular thyroid neoplasia with papillary‐like features (cancer+NIFTP) and 68% malignant diagnosis when excluding NIFTP. RAS‐like alterations were most common (66%), exhibiting a 73.4% ROM and a 59% malignant diagnosis. Interestingly, this group included 24 encapsulated follicular variant papillary thyroid carcinomas (EFVPTCs), 1 infiltrative FVPTC, 9 follicular carcinomas, and 7 NIFTP. Additionally, three high‐risk mutations and eight BRAF/V600E mutations had a 100% ROM, all diagnosed as classic‐type papillary thyroid carcinoma (cPTC). Combined analysis of thyroid nodules from Bethesda III and IV categories revealed a 78.2% positive predictive value (PPV) and a 75.9% negative predictive value (NPV).

Conclusion

ThyroSeq v3 effectively stratifies the ROM in indeterminate thyroid nodules based on specific genetic alterations, guiding appropriate surgical management. Notably, the BRAFV600E/high‐risk group and RAS‐like groups exhibited ROM of 100% and 77.5%, respectively, with promising predictive accuracy (PPV of 78.2% and NPV of 75.9%).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NoduleHumansBiopsy, Fine-NeedleMutationFemaleMaleThyroid NeoplasmsMiddle AgedAdultAged

Stichwörter der Autor:innen

ThyroSeqindeterminate thyroid nodulemutationrisk of malignancysurgical diagnosis

Autor:innen und Institutionen

  • Department of Pathology, Emory University, Atlanta, Georgia, USA.
  • Department of Pathology, Cleveland Clinic Main Campus, Cleveland, Ohio, USA.
  • Biostatistics Shared Resource, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.
  • Department of Hematology & Medical Oncology and Otolaryngology, Emory University, Atlanta, Georgia, USA.
  • Center for the Cancer Research and Therapeutic Development (CCRTD), Clark Atlanta University, Atlanta, Georgia, USA.
  • Department of Otolaryngology, Emory University, Atlanta, Georgia, USA.

ORCID-Profile: Daniel Lubin, Qiuying Shi

Zitieren

APA

Sirotnikov, S., Griffith, C. C., Lubin, D., Zhang, C., Saba, N. F., Li, D., Kornfield, A., Chen, A., & Shi, Q. (2024). ThyroSeq overview on indeterminate thyroid nodules: An institutional experience. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25311

Vancouver

Sirotnikov S, Griffith CC, Lubin D, Zhang C, Saba NF, Li D, et al. ThyroSeq overview on indeterminate thyroid nodules: An institutional experience. Diagnostic Cytopathology. 2024. doi:10.1002/dc.25311

BibTeX
@article{Sirotnikov2024,
  author = {Sirotnikov, Sam and Griffith, Christopher C and Lubin, Daniel and Zhang, Chao and Saba, Nabil F and Li, Dehong and Kornfield, Amanda and Chen, Amy and Shi, Qiuying},
  title = {ThyroSeq overview on indeterminate thyroid nodules: An institutional experience},
  journal = {Diagnostic Cytopathology},
  year = {2024},
  doi = {10.1002/dc.25311}
}
Kostenlos starten →